Saroja Pharma Industries India Ltd

Saroja Pharma In Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Saroja Pharma Industries India Ltd

₹ 51.8 4.55%
05 Sep - close price
Company website NSE - SME: SAROJA
About

Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]

Key Points

Business Overview:[1]
SPIIL is in the business of trading in Pharma API, Pharma Intermediates, Chemicals, Solvents, and other pharmaceutical products, used
for human and veterinary medicine

Website NSE - ST
  • Market Cap ₹ 20.8 Cr.
  • Current Price ₹ 51.8
  • High / Low ₹ 65.0 / 34.0
  • Stock P/E 20.2
  • Book Value ₹ 39.0
  • Dividend Yield 0.00 %
  • ROCE 12.6 %
  • ROE 6.79 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 39.6 days to 29.8 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 10.0% over last 3 years.
  • Company has high debtors of 180 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
26.54 23.73 21.12 19.36 18.72 35.11
25.18 22.28 19.95 18.17 17.58 33.34
Operating Profit 1.36 1.45 1.17 1.19 1.14 1.77
OPM % 5.12% 6.11% 5.54% 6.15% 6.09% 5.04%
0.08 0.00 0.39 0.00 0.07 0.00
Interest 0.68 0.64 0.83 0.62 0.69 0.72
Depreciation 0.00 0.07 0.04 0.06 0.05 0.06
Profit before tax 0.76 0.74 0.69 0.51 0.47 0.99
Tax % 27.63% 27.03% 27.54% 27.45% 27.66% 29.29%
0.55 0.54 0.50 0.38 0.34 0.70
EPS in Rs 24.36 1.84 1.24 0.95 0.85 1.74
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
36.66 55.63 50.19 40.67 53.92
35.36 53.53 47.47 38.11 50.95
Operating Profit 1.30 2.10 2.72 2.56 2.97
OPM % 3.55% 3.77% 5.42% 6.29% 5.51%
0.09 0.32 0.16 0.19 0.00
Interest 0.33 0.80 1.32 1.45 1.41
Depreciation 0.02 0.05 0.07 0.09 0.11
Profit before tax 1.04 1.57 1.49 1.21 1.45
Tax % 28.85% 28.03% 28.86% 27.27% 28.97%
0.73 1.14 1.06 0.88 1.03
EPS in Rs 730.00 50.49 3.61 2.19 2.56
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -1%
TTM: 33%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -3%
TTM: 17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -17%
Return on Equity
10 Years: %
5 Years: %
3 Years: 10%
Last Year: 7%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.01 0.23 2.94 4.02 4.02
Reserves 0.93 3.80 2.15 10.62 11.66
3.02 6.14 10.18 5.73 9.46
4.26 5.34 6.07 6.20 14.41
Total Liabilities 8.22 15.51 21.34 26.57 39.55
0.09 0.34 2.22 2.51 2.51
CWIP 0.00 0.00 1.79 6.13 8.61
Investments 0.00 0.04 0.14 0.20 0.34
8.13 15.13 17.19 17.73 28.09
Total Assets 8.22 15.51 21.34 26.57 39.55

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-1.05 -3.67 2.19 1.02 1.15
-0.05 -0.34 -4.82 -4.76 -2.70
1.03 4.27 2.73 3.70 1.56
Net Cash Flow -0.07 0.26 0.10 -0.04 0.01

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 71.88 91.73 80.80 145.75 179.93
Inventory Days 7.23 3.41 31.18 4.10 0.75
Days Payable 45.43 38.52 47.22 57.45 102.56
Cash Conversion Cycle 33.68 56.62 64.76 92.39 78.12
Working Capital Days 22.20 33.07 17.16 71.71 29.78
ROCE % 33.55% 22.09% 14.93% 12.57%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2023Mar 2024Sep 2024Mar 2025
73.02% 73.02% 73.02% 73.02%
26.99% 26.98% 26.98% 26.98%
No. of Shareholders 597506438422

Documents

Announcements

Annual reports